News | December 08, 2023
Operations disrupted at NATCO Pharma's Manali, Chennai factory
NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises
NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises
Natco Pharma has reported total income of Rs. 1060.8 crores during the period ended September 30, 2023
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
The company is confident of addressing all the observations within the stipulated time
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
NATCO to sell 15% of shareholding in Nativita for euro 3,45,000 to Pharmasyntez-Nord
He has over 25+ years of experience in the pharmaceutical Industry and has been working with the company for the past 6 years
The company has reported total income of Rs. 918.9 crores during the period ended June 30, 2022.
Subscribe To Our Newsletter & Stay Updated
